Linafexor

Overview

Linafexor (CS-0159) is a FXR agonist and bile acid homeostasis modulator. Linafexor exerts its effects by activating FXR , a regulator of liver function. Linafexor is applicable to research related to primary sclerosing cholangitis ( PSC ). Linafexor is also suitable for research in the field of metabolic dysfunction-associated steatohepatitis ( MASH ).

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > FXR

Product Information

• Catalog No.: HY-160929
• CAS No.: 2765593-43-7
• Molecular Formula: C28H25Cl2FN4O4
• Molecular Weight: 571.43
• Purity: 99.58%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (4.37 mM); Clear solution
• Availability: In-stock

Source

Original product source